Jazz Pharmaceuticals (JAZZ) Change in Inventory (2010 - 2026)

Jazz Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at $77.8 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 118.54% year-over-year to $77.8 million; the TTM figure through Mar 2026 stood at $128.2 million (up 87.77% YoY), while the FY2025 annual figure was $86.0 million, up 88.93% from the prior year.
• Change in Inventory for Q1 2026 stood at $77.8 million, up from -$7.7 million in the prior quarter.
• The five-year high for Change in Inventory was $77.8 million in Q1 2026, with the low at -$7.7 million in Q4 2025.
• The 5-year median for Change in Inventory is $9.3 million (2024), against an average of $16.0 million.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 1229.42% in 2024, then tumbled 141.36% in 2025.
• Jazz Pharmaceuticals' Change in Inventory stood at -$816000.0 in 2022, then surged by 272.06% to $1.4 million in 2023, then soared by 1229.42% to $18.7 million in 2024, then slumped by 141.36% to -$7.7 million in 2025, then soared by 1107.77% to $77.8 million in 2026.
• Business Quant data shows JAZZ's Change in Inventory at $77.8 million in Q1 2026, -$7.7 million in Q4 2025, and $31.9 million in Q3 2025.